Résultats de la recherche - 1 result
A dose-escalation study of combretastatin A4-phosphate in healthy dogs.
systolic arterial blood pressure, electrocardiogram, echocardiographic variables and general wellbeing were characterised. Three different doses were tested: 50, 75 and 100 mg m(-2). At all 3 CA4P doses, ...